Odyssey Health (ODYY) Retained Earnings (2014 - 2026)
Odyssey Health's (ODYY) quarterly Retained Earnings came in at $56.2 million in Q2 2026, up 189.95% year-on-year from $19.4 million in Q2 2025, and little changed quarter-over-quarter from $56.1 million in Q1 2026.
Odyssey Health (ODYY) Retained Earnings (2014 - 2026) Analysis & Trends
Odyssey Health's Retained Earnings history runs 13 years deep, the most recent figure standing at $56.2 million for Q2 2026.
- On a quarterly basis, Retained Earnings rose 189.95% year-over-year to $56.2 million in Q2 2026; TTM through Apr 2026 was $56.2 million, a 189.95% increase from a year earlier, with the FY2025 full-year figure at -$62.7 million, down 212.91% from the prior year.
- Retained Earnings was little changed at $56.2 million in Q2 2026 per ODYY's latest filing, from $56.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $56.2 million in Q2 2026 and bottomed at -$63.2 million in Q4 2025.
- The 5-year median for Retained Earnings is -$55.3 million (2022), against an average of -$26.7 million.
- Across the five-year window, Retained Earnings jumped 247.26% in 2022 and plunged 229.43% in 2023, its largest moves.
- Year by year, Retained Earnings stood at -$56.3 million in 2022, then surged by 196.46% to $54.3 million in 2023, then sank by 214.15% to -$62.0 million in 2024, then declined by 1.95% to -$63.2 million in 2025, then surged by 188.91% to $56.2 million in 2026.
- Per Business Quant, the three latest ODYY Retained Earnings figures stand at $56.2 million (Q2 2026), $56.1 million (Q1 2026), and -$63.2 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 2.63 Bn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 5.32 Bn |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 56.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 56.21 Mn |
| Jan 31, 2026 | 56.14 Mn |
| Oct 31, 2025 | -63.23 Mn |
| Jul 31, 2025 | -62.75 Mn |
| Apr 30, 2025 | -62.49 Mn |
| Jan 31, 2025 | -62.24 Mn |
| Oct 31, 2024 | -62.02 Mn |
| Jul 31, 2024 | 55.57 Mn |
| Apr 30, 2024 | -48.26 Mn |
| Jan 31, 2024 | -47.42 Mn |
| Oct 31, 2023 | 54.34 Mn |
| Jul 31, 2023 | -60.10 Mn |
| Apr 30, 2023 | -59.28 Mn |
| Jan 31, 2023 | -58.00 Mn |
| Oct 31, 2022 | -56.33 Mn |
| Jul 31, 2022 | -54.18 Mn |
| Apr 30, 2022 | -52.17 Mn |
| Jan 31, 2022 | 44.81 Mn |
| Oct 31, 2021 | -47.38 Mn |
| Jul 31, 2021 | 42.88 Mn |